Corbus Pharmaceuticals Holdings (CRBP) Receivables (2021)

Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Receivables of $5.0 million in Q3 2021, up 1.99% quarter-over-quarter from $4.9 million in Q2 2021.

Corbus Pharmaceuticals Holdings (CRBP) Receivables (2021) Analysis & Trends

Corbus Pharmaceuticals Holdings' Receivables history runs 1 years deep, the most recent figure standing at $5.0 million for Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 13.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 2.00 Bn
9 Abivax 94.37 Bn 94.37 Bn - -
10 Corbus Pharmaceuticals Holdings 133.67 Mn 105.86 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2021 5.00 Mn
Jun 30, 2021 4.90 Mn
Mar 31, 2021 4.77 Mn